Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ester-E sales

This article was originally published in The Tan Sheet

Executive Summary

Retail sales for Zila's Ester-E vitamin E branded ingredient increased 35% in the 12-week period ended March 19 over the previous year, despite the overall category is 42%, Zila states May 4. The downward trend for vitamin E is the result of publicity surrounding recently published negative studies on the antioxidant. The firm's nationally airing TV and radio ads for branded products Ester-E and Ester-C helped increase revenue by 14% to $9.8 mil. during the firm's fiscal second quarter (1"The Tan Sheet" March 21, 2005, In Brief)...

You may also be interested in...

HSA resources

Fort Lee, N.J.-based Information Strategies offers The Consumer's Guide To Health Savings Accounts book and website to inform consumers on HSA options. The book "helps readers become better-informed healthcare consumers, critical to utilizing this new approach to healthcare," the firm says. More than half of all healthcare policies will involve HSAs by 2010, Information Strategies predicts, claiming more Americans established the accounts in January than in all of 2004...

Legal Notebook: Catalyst’s Suit vs. FDA Is Tossed, Avonex Patent Invalidity Verdict Is Reinstated

Court finds US FDA did not impede Catalyst orphan exclusivity for Firdapse as it approved different indication for competing product. Biogen loses 10-year patent battle against competing multiple sclerosis drug makers.

Naturopath Marketing Brain Defense Supplement Anticipates Support For Making TBI Claims

Cover Three Nutritional Brain Defense marketer agrees to pull claims suggesting the supplement beverage can protect against traumatic brain injury after a test the firm on DHA submitted as support contained considerably higher levels of the ingredient than included in the product.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts